Riskpilot← Back to searchSign inGet full accessFAMMAG AB
ABActiveOrg 5569924128Badvägen 25 AGeneral medical practice activities · NACE 8621Est. 20140 employees
Revenue 2025
SEK 793K
-15% vs 2024
EBITDA margin
83.0%
-19% vs 2024
Equity ratio
64.5%
Financial strength
Net profit 2025
SEK 385K
-19% vs 2024
| Revenue | SEK 793K | -15% |
| EBITDA | SEK 658K | -19% |
| Net profit | SEK 385K | -19% |
| Total assets | SEK 2,5M | +13% |
| Equity | SEK 1,6M | +13% |
| Employees | 0 | — |
Legal name
FAMMAG AB
Org number
5569924128
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
27 november 2014
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva medicinsk behandlings- och konsultverksamhet, ekonomi-, revisions, redovisnings- och marknadsförings- tjänster, uthyrning av transportmedel och inventarier inom hem- och kontorsmiljöer, kapitalförvaltning, egendomsförvaltning samt import och handel av produkter med inriktning på konfektions-, inrednings-, hemelektronik-, livsmedels-, sport och fritids- branschen samt medicinska artiklar.
Address
Badvägen 25 A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 587 | 783 | 1 162 | 928 | 793 |
| Staff expenses | — | −13 | −13 | −15 | −16 |
| EBITDA | 449 | 624 | 1 023 | 810 | 658 |
| Depreciation & amort. | −0 | — | — | −8 | −8 |
| EBIT | 449 | 624 | 1 023 | 802 | 650 |
| Net financials | — | −0 | 1 | −0 | 8 |
| Profit before tax | 449 | 624 | 765 | 602 | 489 |
| Tax | −98 | −130 | −160 | −128 | −104 |
| Net profit | 351 | 494 | 606 | 474 | 385 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 715 | 1 015 | 1 753 | 2 192 | 2 471 |
| Equity | 405 | 715 | 1 133 | 1 412 | 1 592 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 310 | 300 | 362 | 322 | 251 |
| Total debt | 310 | 300 | 362 | 322 | 251 |
EBITDA margin
83.0%
This company
15.8%
Market median
+425% vs market
20212025
Equity ratio
64.5%
This company
38.2%
Market median
+69% vs market
20212025
Return on equity
24.2%
This company
18.4%
Market median
+32% vs market
20212025
Net profit margin
48.5%
This company
8.1%
Market median
+499% vs market
20212025
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
20212025
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FAMMAG AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Boel Christina Magnusson | Deputy Board Member | 0 companies |
| Håkan Ingemar Magnusson | Board of Directors | 0 companies |